In October 2019, the United States Food and Drug Administration (FDA) approved MT1 under the brand name Scenesse for increasing sunlight tolerance and alleviating pain from ultraviolet (UV) light exposure in patients with erythropoietic protoporphyria (EPP) [4]
This is the number we'll work with, as research doses are almost always measured in mcg
"Biotechnology profile: Bright future for Clinuvel (ASX:CUV)"
Naturally, MOTS-c is produced in skeletal muscle and other tissues, where it acts locally and systemically to help maintain metabolic homeostasis
Longevity isnt about reversing timeits about supporting the systems that help you age well
One of the investigations reported that NPs were loaded with nuclear factor kappa B (NF-B) inhibitors, a key regulator of inflammation, which could suppress the microglial activation and decrease the production of pro-inflammatory cytokines